- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05752266
Effect of Probiotics on Amino Acid Absorption
The goal of this clinical trial is to test effects of consuming probiotics in healthy adults. The main question it aims to answer is:
• Do consuming probiotics affect a healthy adult's ability to absorb amino acids from plant proteins?
Participants will
- Consume one dose of probiotic pills per day after meals for two weeks
- Consume one dose of plant-based plant protein beverage after an overnight fast and collection of one 5 ml fasting blood sample
- Undergo blood draw of 6 more 5 ml blood samples for the next 3 hours after consuming plant-based protein beverage
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is increasing evidence that the gut microbiota contributes to a range of immune, inflammatory, and metabolic responses. Numerous studies have shown that administrating probiotics - strains of bacteria that benefits intestinal function - confer benefits to the host's immune system. Except for soy protein, plant proteins are incomplete proteins lacking in one or more essential amino acids. The incomplete amino acid profile of most plant proteins is compounded by their lower rate of absorption as compared to animal protein. Hence, the investigators aim to investigate the administration of probiotics as a potential strategy to overcome compositional shortcomings of plant proteins by improving the gastrointestinal absorption of plant-based proteins.
The aim of Stage 1 is to formulate a plant-based protein beverage with optimized amino acid profile with consumer acceptance.
Stage 2 of this study will be to conduct a randomized, double-blind, placebo-controlled, crossover trial using the formulation developed in Stage 1, together with probiotics supplementation to evaluate the effect of probiotics on the absorption of amino acids from plant proteins.
The probiotics to be studied will be provided by the Asian Microbiome Library (AMILI) with the plant protein beverage to be developed within SIT. Findings from this mutually beneficial collaborative project with AMILI will pave the way to further understand the role of probiotics in human health, particularly its effect in nutrient absorption of plant protein.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sinagpore
-
Singapore, Sinagpore, Singapore, 138683
- Verena Tan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Be willing and able to comply with study procedures and give written informed consent
- Self-reported to be healthy
- Within healthy BMI weight range (18.5-23kg/m2)
Exclusion Criteria:
- Any chronic medical condition
- Individuals who were treated for or diagnosed with a gastrointestinal, cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, autoimmune, haematological, neurological or endocrinological disorder
- Antibiotic use
- Prebiotics, probiotics, synbiotics, and/or digestive enzymes use
- Food allergy/intolerances/avoidances towards eggs, soya, peanuts, tree nuts, crustaceans, and gluten
- Smoking
- Alcohol consumption
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Probiotic Arm
Participants allocated to PRO arm will be administered personalized probiotic pills.
|
AMILI (AMILI Pte Ltd) will analyze stool samples provided by participants, and assign each participant a type of probiotic pill from the 5 different types of probiotic pills commercially available in AMILI retail store.
|
|
Placebo Comparator: Placebo Arm
Participants allocated to PRO arm will be administered maltodextrin placebo pills similar in appearance to probiotic pills.
|
Placebo pills contaning maltodextrin with similar appearance to Probiotic pills will be provided to participants allocated to the Placebo Arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in blood amino acid concentration
Time Frame: 0 to 150 minutes after ingestion of plant protein beverage on each study visit
|
Following ingestion of plant protein beverage, participants will be subjected to drawing of serial blood samples after consuming the plant protein beverage. These blood samples will be analyzed for amino acid profile using mass spectrometry methods. |
0 to 150 minutes after ingestion of plant protein beverage on each study visit
|
|
Change in gut microbiota type
Time Frame: 0 to 6 weeks after start of study
|
Paricipants will provide a stool sample on each study visit (3 stool samples in total throughout the study).
These stool samples given will be analyzed for any changes in type and population size of gut microbes of participants after probiotic intervention and placebo comparator intervention.
|
0 to 6 weeks after start of study
|
|
Change in gut microbiota population size
Time Frame: 0 to 6 weeks after start of study
|
Paricipants will provide a stool sample on each study visit (3 stool samples in total throughout the study).
These stool samples given will be analyzed for any changes in type and population size of gut microbes of participants after probiotic intervention and placebo comparator intervention.
|
0 to 6 weeks after start of study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in blood glucose level
Time Frame: 0 to 150 minutes after ingestion of plant protein beverage
|
Following ingestion of plant protein beverage, participants will be subjected to drawing of serial blood samples after consuming the plant protein beverage. Serial blood samples will be analyzed for glucose profile using mass spectrometry methods. |
0 to 150 minutes after ingestion of plant protein beverage
|
|
Change in blood insulin level
Time Frame: 0 to 150 minutes after ingestion of plant protein beverage
|
Following ingestion of plant protein beverage, participants will be subjected to drawing of serial blood samples after consuming the plant protein beverage. Serial blood samples will be analyzed for insulin profile using mass spectrometry methods. |
0 to 150 minutes after ingestion of plant protein beverage
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Verena Tan, M.Nutr.Diet, +65 9172 4062
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2022180
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Microbiome
-
The Gut Microbiome Center (Centar za crijevni mikrobiom)University of ZagrebCompletedGastrointestinal MicrobiomeCroatia
-
University of GlasgowActive, not recruitingGastrointestinal MicrobiomeUnited Kingdom
-
Mizu JiangUnknown
-
SunWay Biotech Co., LTD.CompletedGastrointestinal MicrobiomeTaiwan
-
Mead Johnson NutritionTerminatedGastrointestinal MicrobiomeUnited States
-
SunWay Biotech Co., LTD.National Taiwan University Hospital; Chung Shan Medical UniversityCompletedGastrointestinal MicrobiomeTaiwan
-
Shanghai 10th People's HospitalUnknown
-
Washington University School of MedicineCompletedMicrobiota | Gastrointestinal MicrobiomeUnited States
-
Chr Hansen - part of NovonesisRecruitingGastrointestinal Symptoms | Gastrointestinal Microbiome (Focus)Ireland
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingGastrointestinal Microbiome | Hydrogen SulfideUnited States
Clinical Trials on AMILI Probiotic pills
-
Beijing Tiantan HospitalTasly Pharmaceutical Group Co., LtdActive, not recruiting
-
China National Center for Cardiovascular DiseasesFuwai Yunnan Cardiovascular HospitalRecruitingCoronary Heart Disease | Medicine, Chinese TraditionalChina
-
University of Maryland, BaltimoreRecruiting
-
Virginia Commonwealth UniversityCompleted
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Dalian UniversityUnknown
-
Dongzhimen Hospital, BeijingNot yet recruiting
-
Guangzhou University of Traditional Chinese MedicineNot yet recruitingAcute Coronary Syndrome
-
State Administration of Traditional Chinese Medicine...UnknownIschemic Heart FailureChina